"The innovative and meaningful solutions provided by Specialty Networks allow independent GI practices to improve patient outcomes, drive ancillary revenues, operate more efficiently, and lower costs. This fantastic opportunity will help practices across the nation advance the standard of care for their patients," said Steve Somers and Chris Metz, Principals, Gastrologix.
Haverford Healthcare Advisors served as M&A advisor, and Saxton & Stump served as legal advisor to Gastrologix. Katten Muchin Rosenman, LLC served as legal advisor to Specialty Networks.
Ad Statistics
Times Displayed: 114080
Times Visited: 6783 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About Specialty Networks, LLC
Specialty Networks ("SN") is an integrated, multi-specialty platform with GPOs (Group Purchasing Organizations), Life Sciences, and Research solutions in gastroenterology, urology, and rheumatology. SN solutions include patient population health management, patient engagement, clinical research, and workflow automation technologies to achieve Center of Excellence in Standards of Care, Clinical Research, Practice Operations, and Value-based Care. SN leverages the power of its network, represented by over 11,000 providers, to help independent physician practices, industry, wholesalers/distributors, payers, and policymakers improve patient outcomes.
Specialty Networks is a portfolio company of Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country's largest dedicated healthcare private equity firms. Linden's strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested in over 40 healthcare companies encompassing over 200 total transactions. The firm has raised over $6.5 billion in limited partner commitments since inception.
Back to HCB News
